Develops novel inhibitors targeting InhA, aiming to combat multidrug-resistant tuberculosis, highlighting the need for effective treatments.
The updated guidelines from the World Health Organization highlight that treatment options for multidrug-resistant tuberculosis (MDR-TB) remain limited due to the scarcity of effective drugs.
No takes yet. Share an insight, caveat, or question.
Sabt et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: